BioCentury
ARTICLE | Clinical News

Dexosome-based cancer vaccine: Phase II

October 28, 2002 8:00 AM UTC

Anosys disclosed that it started in July a U.S. Phase II study of its dexosome-based cancer vaccine in 60 melanoma patients. ...